Sort
30,917 grants matching “tumor microenvironment”
Defining the contributions of Lyve-1 expressing macrophages to breast cancer growth and progression
$414,689Kathryn L Schwertfeger · University Of Minnesota · R01 · FY2025 · CA
Neuroimmunology of Malignant Brain Tumors: Innate Mechanisms
$414,676Pedro R Lowenstein · University Of Michigan At Ann Arbor · R01 · FY2017 · NS
Neuroimmunology of Malignant Brain Tumors: Innate Mechanisms
$414,676Pedro R Lowenstein · University Of Michigan At Ann Arbor · R01 · FY2019 · NS
Neuroimmunology of Malignant Brain Tumors: Innate Mechanisms
$414,676Pedro R Lowenstein · University Of Michigan At Ann Arbor · R01 · FY2018 · NS
Neuroimmunology of Malignant Brain Tumors: Innate Mechanisms
$414,676Pedro R Lowenstein · University Of Michigan At Ann Arbor · R01 · FY2020 · NS
Role of Src family kinases in endothelial cell biology
$414,600La Jolla Inst For Molecular Medicine · R01 · FY2002 · HL
Spatial Analysis of Molecules in Tissue using MALDI-MS
$414,588Richard M Caprioli · Vanderbilt University · R01 · FY2013 · GM
Project 2: Immune signals promoting pancreas cancer stemness and progression
$414,574Steven E Artandi · Stanford University · P01 · FY2022 · CA
Non-essential amino acids and sphingolipid diversity in cancer progression
$414,574Christian Michael Metallo · Salk Institute For Biological Studies · R01 · FY2023 · CA
Non-essential amino acids and sphingolipid diversity in cancer progression
$414,574Christian Michael Metallo · Salk Institute For Biological Studies · R01 · FY2022 · CA
Project 2: Immune signals promoting pancreas cancer stemness and progression
$414,571Steven E Artandi · Stanford University · P01 · FY2023 · CA
Transfer of microRNA regulators from glioblastoma to brain microenvironment
$414,537Xandra Owens Breakefield · Massachusetts General Hospital · U19 · FY2013 · CA
Novobiocin-mediated polymerase theta inhibition in homologous recombination repair-deficient cancers
$414,529Geoffrey I Shapiro · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Project 3. Overcoming Melanoma Treatment Resistance with Cytokine Immunotherapy
$414,525Aaron Michael Ring · Yale University · P50 · FY2024 · CA
PROJECT 2: NF1-associated Glioblastoma
$414,508Luis F Parada · Indiana University Indianapolis · U54 · FY2022 · CA
LILRB modulates tumor microenvironment and promotes tumor progression
$414,496Shu-Hsia Chen · Methodist Hospital Research Institute · R01 · FY2022 · CA
Arming Oncolytic HSV Vectors to Induce Anti-GBM Immune Responses in Syngeneic Mice
$414,488Joseph C. Glorioso · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · CA
Understanding functional roles and regulation of granzymes
$414,480Euna Yoo · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Exosome-Dependent Trafficking of Epstein-Barr Virus LMP1
$414,462David G Meckes · Florida State University · R15 · FY2015 · CA
Regional and lobular heterogeneity of human pancreas morphology and function in type 1 diabetes pathogenesis
$414,435Mark A Atkinson · University Of Florida · R01 · FY2022 · DK
Adoptive Therapy of Ovarian Cancer with Autologous Genetically Modified T Cells
$414,354Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · P01 · FY2015 · CA
The microbiome associated with oral Leukoplakia: A multi-omics mechanistic study
$414,348Nezar Al-Hebshi · Temple Univ Of The Commonwealth · R56 · FY2023 · DE
Biomarker Developmental Laboratory (BDL)
$414,309Steven J Skates · Massachusetts General Hospital · U2C · FY2023 · CA
Personalizing immunotherapy in HER2+ breast cancer through quantitative imaging
$414,223Anna C Sorace · University Of Alabama At Birmingham · R01 · FY2020 · CA
Project 04 - Develop a portfolio of agents for switching that match biology of residual tumor burden
$414,197Douglas Yee · University Of California, San Francisco · P01 · FY2018 · CA